Hiroshi Kurahara
Overview
Explore the profile of Hiroshi Kurahara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
205
Citations
2450
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baba S, Kawasaki T, Hirano S, Nakamura T, Asano T, Okazaki R, et al.
EClinicalMedicine
. 2025 Jan;
78():102936.
PMID: 39764541
Background: Pancreatic cancer is highly aggressive and has a low survival rate primarily due to late-stage diagnosis and the lack of effective early detection methods. We introduce here a novel,...
2.
Nakamura S, Nakata K, Nagakawa Y, Kozono S, Wakabayashi G, Wakabayashi T, et al.
J Hepatobiliary Pancreat Sci
. 2024 Dec;
32(2):124-131.
PMID: 39711213
Background/purpose: The Japanese public health insurance system has recently covered robotic pancreaticoduodenectomy (RPD). This study aimed to review the results of RPD during the introductory period and elucidate its safety...
3.
Yoshidome S, Sasaki K, Fumoto H, Tsuruda Y, Shimonosono M, Uchikado Y, et al.
Gen Thorac Cardiovasc Surg Cases
. 2024 Nov;
2(1):103.
PMID: 39516953
Background: Aortic-esophageal fistula (AEF) after thoracic endovascular aortic repair (TEVAR) has a high fatality rate and is difficult to treat. Endoluminal vacuum therapy (EVT) has recently appeared and proven to...
4.
Ariake K, Mizuma M, Unno M, Satoi S, Yamamoto N, Hayashi M, et al.
J Hepatobiliary Pancreat Sci
. 2024 Sep;
32(1):69-81.
PMID: 39317950
Background: The aim of this study was to determine the optimal treatment for patients with pancreatic cancer (PaCa) having positive peritoneal cytology (PPC). Methods: This multicenter retrospective study included patients...
5.
Hirashita T, Ikenaga N, Nakata K, Nakamura M, Kurahara H, Ohtsuka T, et al.
Ann Gastroenterol Surg
. 2024 Jul;
8(4):681-690.
PMID: 38957555
Background: Distal pancreatectomy (DP) with lymph node (LN) dissection is the standard procedure for pancreatic ductal adenocarcinoma of the tail (Pt-PDAC). However, the optimal surgery including extent of LN dissection...
6.
Hidaka Y, Tanoue S, Ayukawa T, Takumi K, Noguchi H, Higashi M, et al.
J Gastroenterol
. 2024 Jun;
59(9):858-868.
PMID: 38900299
Background: Pancreatic ductal occlusion can accompany pancreatic head cancer, leading to pancreatic exocrine insufficiency (PEI) and adverse effects on nutritional status and postoperative outcomes. We investigated its impact on nutritional...
7.
Oi H, Hozaka Y, Akahane T, Fukuda K, Idichi T, Tanoue K, et al.
Pancreas
. 2024 May;
53(10):e790-e795.
PMID: 38743932
Objective: The role of Krüppel-like transcription factor 4 ( KLF4 ) mutations in IPMNs with concomitant pancreatic ductal adenocarcinoma (PDAC) remains unclear. This study clarified the rate and effect of...
8.
Hirase Y, Arigami T, Kawasaki Y, Matsushita D, Shimonosono M, Tsuruda Y, et al.
Surg Case Rep
. 2024 Mar;
10(1):51.
PMID: 38438775
Background: Conversion surgery (CS) after chemotherapy is weakly recommended as a promising tool for improving prognoses in patients with unresectable gastric cancer. Moreover, several investigators have demonstrated the clinical efficacy...
9.
Ikenaga N, Hashimoto T, Mizusawa J, Kitabayashi R, Sano Y, Fukuda H, et al.
BMC Cancer
. 2024 Feb;
24(1):231.
PMID: 38373949
Background: Minimally invasive distal pancreatectomy (MIDP), including laparoscopic and robotic distal pancreatectomy, has gained widespread acceptance over the last decade owing to its favorable short-term outcomes. However, evidence regarding its...
10.
Shimonosono M, Arigami T, Matsushita D, Tsuruda Y, Sasaki K, Baba K, et al.
Anticancer Res
. 2023 Dec;
44(1):387-396.
PMID: 38159990
Background/aim: The clinical significance of laparoscopic subtotal gastrectomy (LsTG) with a small remnant stomach remains unclear in patients with gastric cancer, including at an advanced stage. The present study assessed...